Korea Introduces Regulatory Guidelines for Synthetic Peptide Drugs, Including GLP-1 Analogs

News Healthcare & Pharma Guidance

Date: 30th Apr, 2025 Source: Korea Food and Drug Administration (KFDA) Country: South Korea Original Source

Brief

On 30/04/2025, the Korea Food and Drug Administration (KFDA) issued an update regarding "Korea Introduces Regulatory Guidelines for Synthetic Peptide Drugs, Including GLP-1 Analogs". The KFDA hosted a meeting with synthetic peptide drug developers to discuss regulatory support for product development and approval of these drugs.

This content is restricted.

Highlights content goes here...

This content is restricted.

Korea Food and Drug Administration (KFDA)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Korea Introduces Regulatory Guidelines for Synthetic Peptide Drugs, Including GLP-1 Analogs

Brief

Korea Food and Drug Administration (KFDA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Korea Introduces Regulatory Guidelines for Synthetic Peptide Drugs, Including GLP-1 Analogs

Brief

Korea Food and Drug Administration (KFDA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.